Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-12

AUTHORS

Per-Göran Larsson, Babill Stray-Pedersen, Kjeld R Ryttig, Stig Larsen

ABSTRACT

BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834. More... »

PAGES

3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6874-8-3

DOI

http://dx.doi.org/10.1186/1472-6874-8-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005792714

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18197974


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravaginal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clindamycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Confidence Intervals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactobacillus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norway", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probiotics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Secondary Prevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vagina", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginosis, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Women's Health", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, K\u00e4rnsjukhuset, SE-541 85, Sk\u00f6vde, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsson", 
        "givenName": "Per-G\u00f6ran", 
        "id": "sg:person.012634564012.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stray-Pedersen", 
        "givenName": "Babill", 
        "id": "sg:person.0631122174.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Farmaservice, DK-2990, Niv\u00e5, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryttig", 
        "givenName": "Kjeld R", 
        "id": "sg:person.010725643124.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian University of Life Sciences", 
          "id": "https://www.grid.ac/institutes/grid.19477.3c", 
          "name": [
            "Norwegian School of Veterinary Science, also Ullev\u00e5l University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsen", 
        "givenName": "Stig", 
        "id": "sg:person.013272512512.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ajog.2005.11.041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003579888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007778437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(83)91112-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008512415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_01.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029477183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1471-0528.2006.00946.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032365488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/503780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034159474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-8244(02)00465-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038163667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jcm.40.8.2746-2749.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046109635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.micinf.2006.01.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049637601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00015550410022249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058255052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074813072", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076994697", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077230119", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077315051", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078295192", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-12", 
    "datePublishedReg": "2008-12-01", 
    "description": "BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure.\nMETHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial.\nRESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding \"Time from cure to relapse\" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05)\nCONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up.\nTRIAL REGISTRATION NUMBER: ISRCTN62879834.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1472-6874-8-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028438", 
        "issn": [
          "1472-6874"
        ], 
        "name": "BMC Women's Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study", 
    "pagination": "3", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18197974"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088690"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6874-8-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005792714"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6874-8-3", 
      "https://app.dimensions.ai/details/publication/pub.1005792714"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1472-6874-8-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      21 PREDICATES      69 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6874-8-3 schema:about N0ce8bf13bfaa42cc9490778e10acb46e
2 N0fd09b46331f46ee9d289b61c59566aa
3 N14f17129ab0f466497a05a314e9fb4aa
4 N18a630d028bb462e935c0feaab90cda5
5 N1d552187609643b59f57c7d0691edd03
6 N28f064b9b638497e94718af5ee9342ef
7 N345de28791a148e8bff92476adac023a
8 N52a5db3eda20468f80ec3188a21ea95c
9 N63e266889d94428db546182440395833
10 N66ee5eb9927a4836a53acf0ed814d7b1
11 N704db08f2c3948a1b37e8d04baae08f2
12 N7b8a80e16155409b92b9e9d8edd6fba8
13 N7bf44c903abb4b1abfa2fc31f2752194
14 N9566cdae6b104a218dbcaa3edfbdf761
15 N97cacafd8cb4442c8969f32fa9a86e6e
16 Na132da8c39ec430ca32f2c973de9fc65
17 Na8d8ef4c66ca4d65838c3989d1f0338a
18 Ndf021602410d44518c6f244cd6813644
19 Ne0f8ecd0d7694ff795db59a0af8c2733
20 Nedcb1d5f3ba54084819dfd6d19544e58
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N23ef2732dfba4ceaabcc8485720b7d06
24 schema:citation https://app.dimensions.ai/details/publication/pub.1074813072
25 https://app.dimensions.ai/details/publication/pub.1076994697
26 https://app.dimensions.ai/details/publication/pub.1077230119
27 https://app.dimensions.ai/details/publication/pub.1077315051
28 https://app.dimensions.ai/details/publication/pub.1078295192
29 https://doi.org/10.1016/0002-9343(83)91112-9
30 https://doi.org/10.1016/j.ajog.2005.11.041
31 https://doi.org/10.1016/j.micinf.2006.01.003
32 https://doi.org/10.1016/s0928-8244(02)00465-0
33 https://doi.org/10.1080/00015550410022249
34 https://doi.org/10.1086/503780
35 https://doi.org/10.1097/00007435-199205000-00007
36 https://doi.org/10.1111/j.1471-0528.2006.00946.x
37 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x
38 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x
39 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x
40 https://doi.org/10.1128/jcm.40.8.2746-2749.2002
41 https://doi.org/10.1136/bmj.308.6924.295
42 https://doi.org/10.1136/sti.2003.006106
43 https://doi.org/10.1136/sti.78.6.413
44 schema:datePublished 2008-12
45 schema:datePublishedReg 2008-12-01
46 schema:description BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N0c8a6ce64cc540289fc4461db8b071f2
51 N3b07b24a498a4999a8dff05937337239
52 sg:journal.1028438
53 schema:name Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
54 schema:pagination 3
55 schema:productId N4ceb3fe9168841038d4d2acb9515b7d2
56 N5d230b01c98e4a54b76d0cb621b2c442
57 N63a6ecef30ec4ecf94546c536c218f96
58 Nb0cc6a5a4cae45d298d8c7ea9ed5c212
59 Nb739297b554147eb9f8799b99c8f1bc3
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005792714
61 https://doi.org/10.1186/1472-6874-8-3
62 schema:sdDatePublished 2019-04-10T19:08
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N2c9c47f5da2949da98001d8a71803fdc
65 schema:url http://link.springer.com/10.1186%2F1472-6874-8-3
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0c8a6ce64cc540289fc4461db8b071f2 schema:volumeNumber 8
70 rdf:type schema:PublicationVolume
71 N0ce8bf13bfaa42cc9490778e10acb46e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Middle Aged
73 rdf:type schema:DefinedTerm
74 N0fd09b46331f46ee9d289b61c59566aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N14f17129ab0f466497a05a314e9fb4aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Administration, Oral
79 rdf:type schema:DefinedTerm
80 N18a630d028bb462e935c0feaab90cda5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Adult
82 rdf:type schema:DefinedTerm
83 N1d552187609643b59f57c7d0691edd03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 N23ef2732dfba4ceaabcc8485720b7d06 rdf:first sg:person.012634564012.84
87 rdf:rest Nf1c0647e847d4274bb5c55e697f6ebb1
88 N28f064b9b638497e94718af5ee9342ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Double-Blind Method
90 rdf:type schema:DefinedTerm
91 N2c9c47f5da2949da98001d8a71803fdc schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 N345de28791a148e8bff92476adac023a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Secondary Prevention
95 rdf:type schema:DefinedTerm
96 N3b07b24a498a4999a8dff05937337239 schema:issueNumber 1
97 rdf:type schema:PublicationIssue
98 N463e4b5b000549e495247adf304c1b7d schema:name Farmaservice, DK-2990, Nivå, Denmark
99 rdf:type schema:Organization
100 N4ceb3fe9168841038d4d2acb9515b7d2 schema:name doi
101 schema:value 10.1186/1472-6874-8-3
102 rdf:type schema:PropertyValue
103 N52a5db3eda20468f80ec3188a21ea95c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Administration, Intravaginal
105 rdf:type schema:DefinedTerm
106 N57da5b04abf24ddb8f367a86ef6555cd rdf:first sg:person.013272512512.34
107 rdf:rest rdf:nil
108 N5d230b01c98e4a54b76d0cb621b2c442 schema:name pubmed_id
109 schema:value 18197974
110 rdf:type schema:PropertyValue
111 N63a6ecef30ec4ecf94546c536c218f96 schema:name readcube_id
112 schema:value 1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e
113 rdf:type schema:PropertyValue
114 N63e266889d94428db546182440395833 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Follow-Up Studies
116 rdf:type schema:DefinedTerm
117 N66ee5eb9927a4836a53acf0ed814d7b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Women's Health
119 rdf:type schema:DefinedTerm
120 N704db08f2c3948a1b37e8d04baae08f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Clindamycin
122 rdf:type schema:DefinedTerm
123 N762bd04aebd647a59c46cb58a02bec35 schema:name Department of Obstetrics and Gynaecology, Kärnsjukhuset, SE-541 85, Skövde, Sweden
124 rdf:type schema:Organization
125 N7b8a80e16155409b92b9e9d8edd6fba8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Vagina
127 rdf:type schema:DefinedTerm
128 N7bf44c903abb4b1abfa2fc31f2752194 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Anti-Bacterial Agents
130 rdf:type schema:DefinedTerm
131 N9566cdae6b104a218dbcaa3edfbdf761 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Confidence Intervals
133 rdf:type schema:DefinedTerm
134 N97cacafd8cb4442c8969f32fa9a86e6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Vaginosis, Bacterial
136 rdf:type schema:DefinedTerm
137 Na132da8c39ec430ca32f2c973de9fc65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Combined Modality Therapy
139 rdf:type schema:DefinedTerm
140 Na8d8ef4c66ca4d65838c3989d1f0338a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Norway
142 rdf:type schema:DefinedTerm
143 Nb0cc6a5a4cae45d298d8c7ea9ed5c212 schema:name nlm_unique_id
144 schema:value 101088690
145 rdf:type schema:PropertyValue
146 Nb739297b554147eb9f8799b99c8f1bc3 schema:name dimensions_id
147 schema:value pub.1005792714
148 rdf:type schema:PropertyValue
149 Nc383d8a6b2e7457fbbdc1764c688517e schema:name Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway
150 rdf:type schema:Organization
151 Ncf796de53bf045feba19a21572ce1ac9 rdf:first sg:person.010725643124.05
152 rdf:rest N57da5b04abf24ddb8f367a86ef6555cd
153 Ndf021602410d44518c6f244cd6813644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Probiotics
155 rdf:type schema:DefinedTerm
156 Ne0f8ecd0d7694ff795db59a0af8c2733 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Lactobacillus
158 rdf:type schema:DefinedTerm
159 Nedcb1d5f3ba54084819dfd6d19544e58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Odds Ratio
161 rdf:type schema:DefinedTerm
162 Nf1c0647e847d4274bb5c55e697f6ebb1 rdf:first sg:person.0631122174.01
163 rdf:rest Ncf796de53bf045feba19a21572ce1ac9
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
168 schema:name Clinical Sciences
169 rdf:type schema:DefinedTerm
170 sg:journal.1028438 schema:issn 1472-6874
171 schema:name BMC Women's Health
172 rdf:type schema:Periodical
173 sg:person.010725643124.05 schema:affiliation N463e4b5b000549e495247adf304c1b7d
174 schema:familyName Ryttig
175 schema:givenName Kjeld R
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05
177 rdf:type schema:Person
178 sg:person.012634564012.84 schema:affiliation N762bd04aebd647a59c46cb58a02bec35
179 schema:familyName Larsson
180 schema:givenName Per-Göran
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84
182 rdf:type schema:Person
183 sg:person.013272512512.34 schema:affiliation https://www.grid.ac/institutes/grid.19477.3c
184 schema:familyName Larsen
185 schema:givenName Stig
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34
187 rdf:type schema:Person
188 sg:person.0631122174.01 schema:affiliation Nc383d8a6b2e7457fbbdc1764c688517e
189 schema:familyName Stray-Pedersen
190 schema:givenName Babill
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01
192 rdf:type schema:Person
193 https://app.dimensions.ai/details/publication/pub.1074813072 schema:CreativeWork
194 https://app.dimensions.ai/details/publication/pub.1076994697 schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1077230119 schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1077315051 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1078295192 schema:CreativeWork
198 https://doi.org/10.1016/0002-9343(83)91112-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008512415
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.ajog.2005.11.041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003579888
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.micinf.2006.01.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049637601
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0928-8244(02)00465-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163667
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1080/00015550410022249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058255052
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1086/503780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034159474
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1097/00007435-199205000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037521551
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1471-0528.2006.00946.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032365488
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007778437
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029477183
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005630776
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1128/jcm.40.8.2746-2749.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046109635
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1136/bmj.308.6924.295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062767566
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1136/sti.2003.006106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023980654
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/sti.78.6.413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019639706
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.19477.3c schema:alternateName Norwegian University of Life Sciences
229 schema:name Norwegian School of Veterinary Science, also Ullevål University Hospital, Oslo, Norway
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...